「discrimination」の検索結果

Detects and removes doublets/aggregates from flow, spectral, and mass cytometry before clustering or quantification. Covers FSC-A vs FSC-H singlet discrimination (the Area-Height non-proportionality, not a 1D area gate), FSC-W/SSC width gating, CyTOF Gaussian discrimination parameters (Center/Offset/Width/Residual/Event_length) and DNA intercalator gating, and the residual heterotypic conjugates that survive scatter gating and masquerade as double-positive populations. Use when filtering aggregates before phenotyping, choosing a doublet method for flow vs CyTOF, or diagnosing a suspicious double-positive cluster.

日本語の概要は準備中です。原文の説明を表示しています。

Assesses AI bias risks for GDPR Art. 9 special category data and AI Act Art. 10 data governance. Covers fairness metrics, bias detection methods, mitigation strategies, and documentation requirements for protected characteristics. Keywords: AI bias, special category, fairness metrics, discrimination, Art. 9, Art. 10.

日本語の概要は準備中です。原文の説明を表示しています。

Detects and removes doublets/aggregates from flow, spectral, and mass cytometry before clustering or quantification. Covers FSC-A vs FSC-H singlet discrimination (the Area-Height non-proportionality, not a 1D area gate), FSC-W/SSC width gating, CyTOF Gaussian discrimination parameters (Center/Offset/Width/Residual/Event_length) and DNA intercalator gating, and the residual heterotypic conjugates that survive scatter gating and masquerade as double-positive populations. Use when filtering aggregates before phenotyping, choosing a doublet method for flow vs CyTOF, or diagnosing a suspicious double-positive cluster.

日本語の概要は準備中です。原文の説明を表示しています。

Detects and removes doublets/aggregates from flow, spectral, and mass cytometry before clustering or quantification. Covers FSC-A vs FSC-H singlet discrimination (the Area-Height non-proportionality, not a 1D area gate), FSC-W/SSC width gating, CyTOF Gaussian discrimination parameters (Center/Offset/Width/Residual/Event_length) and DNA intercalator gating, and the residual heterotypic conjugates that survive scatter gating and masquerade as double-positive populations. Use when filtering aggregates before phenotyping, choosing a doublet method for flow vs CyTOF, or diagnosing a suspicious double-positive cluster.

日本語の概要は準備中です。原文の説明を表示しています。

Detects and removes doublets/aggregates from flow, spectral, and mass cytometry before clustering or quantification. Covers FSC-A vs FSC-H singlet discrimination (the Area-Height non-proportionality, not a 1D area gate), FSC-W/SSC width gating, CyTOF Gaussian discrimination parameters (Center/Offset/Width/Residual/Event_length) and DNA intercalator gating, and the residual heterotypic conjugates that survive scatter gating and masquerade as double-positive populations. Use when filtering aggregates before phenotyping, choosing a doublet method for flow vs CyTOF, or diagnosing a suspicious double-positive cluster.

日本語の概要は準備中です。原文の説明を表示しています。

Feature planning and implementation with 4 adaptive phases (Specify, Design, Tasks, Execute). Auto-sizes depth by complexity. Writes testable requirements in EARS notation, atomic tasks, atomic Conventional Commits, and requirement traceability. Ships deterministic Python validation scripts so structural gates are enforced by code, not memory. Features an independent Verifier (author != verifier, evidence-or-zero), a discrimination sensor, a decision log (STATE.md), a test-coverage matrix, and a self-improving lessons layer. Stack-agnostic and tool-agnostic. Use when (1) planning features, (2) implementing with verification and atomic commits, (3) validating an implementation against a spec. Triggers on "specify feature", "discuss feature", "design", "tasks", "implement", "validate", "verify work", "UAT", "record decision", "pause work", "resume work". Do NOT use for pure architecture decomposition analysis or standalone technical design documents.

日本語の概要は準備中です。原文の説明を表示しています。

Rigorous, defensible email-spoofability verdict and SPF supply-chain risk analysis computed from published DNS alone. Deepens the record-level SPF/DMARC/DKIM/BIMI/MTA-STS/DNSSEC fetch recipes in the offensive-osint arsenal (§16.14) with the reasoning that section doesn't do: a priority-ordered composite verdict for whether an attacker can actually land header-From-spoofed mail in an inbox, and by which vector (exact-domain vs subdomain) — grounded in the single most-misunderstood distinction in email security: the envelope MAIL FROM that SPF authenticates vs the visible header From: that only DMARC governs. Explains precisely why SPF -all/~all alone is NOT spoof-proof without DMARC enforcement, and why SPF +all bypasses DMARC even under p=reject pct=100. Covers RFC 7208 §4.6.4's 10-DNS-lookup / 2-void-lookup PermError fail-open condition with a runnable stdlib-only lookup-counter script, plus the SPF-include-takeover supply-chain vector (an attacker re-registering a dead include inherits SPF-pass authority over the victim domain) with strict transient-vs-NXDOMAIN discrimination discipline so a temporary SERVFAIL is never mistaken for a takeover lead. Fully passive: DNS TXT reads only, no mail sent, no RCPT TO probe, no API keys. Use when auditing a domain's real spoofing resistance (not just its published records), explaining to a client why 'we have SPF -all' does not mean they're covered, investigating an SPF PermError or an unusually long include chain, evaluating a dead SPF include as a takeover lead, or writing a defensible spoofability finding for a deliverable.

日本語の概要は準備中です。原文の説明を表示しています。

Use when evaluating the clinical utility of a binary prediction model from a single clinical CSV file by fitting a logistic decision-curve model, plotting decision and clinical-impact curves, and exporting summary outputs. NOT for: survival calibration, ROC-only discrimination analysis, nomogram construction, or time-to-event outcomes.

日本語の概要は準備中です。原文の説明を表示しています。

A jurisdiction-grounding reference file for AI assistants working on Gibraltar legal, regulatory, and compliance research. Corrects systematic errors AI models make when applying English law to Gibraltar — a distinct jurisdiction under the Gibraltar Constitution Order 2006, with its own court hierarchy, civil procedure rules, employment law, and regulatory framework. Covers the source hierarchy, court structure, civil procedure divergences (14-day deemed service, post-Jackson reforms not adopted), employment law specifics (uncapped discrimination awards, 5-employee redundancy threshold), FSC financial services regulation, AML/KYC compliance sources, Gibraltar Companies Act 2014 with UBO public register, and a structured directory of official public record sources. Includes research profiles for lawyers, compliance professionals, and due diligence practitioners. Not legal advice.

日本語の概要は準備中です。原文の説明を表示しています。

Manages California Consumer Privacy Act (CCPA) consumer rights requests under Civil Code sections 1798.100-125, covering the right to know, right to delete, right to opt-out of sale, and non-discrimination. Includes 45-day response window and identity verification requirements. Activate for CCPA, California privacy, right to know, right to delete, opt-out of sale queries.

日本語の概要は準備中です。原文の説明を表示しています。

Quantitative stock screening, forward-looking valuation outlier detection, backward-looking financial statement validation, PEG ratio analysis, earnings growth profile assessment, turnaround vs value trap discrimination, data mining bias prevention

日本語の概要は準備中です。原文の説明を表示しています。

Think and work like an expert Genetic Counselor. Use when a task calls for Genetic Counselor judgment. Reasons from probabilistic penetrance, Bayesian pretest probability, and patient autonomy through three-generation pedigrees, ACMG/AMP variant criteria, ClinVar/ClinGen/gnomAD, NCCN and CPIC guidelines, and cascade-testing protocols while treating VUS over-upgraded to pathogenic, screening-versus-diagnostic confusion (NIPT vs amnio/CVS), and unaddressed psychosocial and GINA discrimination risk as first-class failure modes.

日本語の概要は準備中です。原文の説明を表示しています。

Think and work like an expert Astrochemist. Use when a task calls for Astrochemist judgment. Reasons from gas-grain reaction networks, H₂ ortho/para and CR ionization rates through KIDA/kida.uva.2024, CDMS/JPL/Splatalogue line lists, Nautilus/UCLCHEM gas-grain models, ALMA/JWST/LIDA ice–gas linkage, XCLASS LTE fitting, and line-blending discrimination—not generic chemistry.

日本語の概要は準備中です。原文の説明を表示しています。

Conduct Fundamental Rights Impact Assessments (FRIA) for high-risk AI systems as required by EU AI Act Article 27. Use when (1) deployers of high-risk AI systems (Annex III) need to assess fundamental rights impacts before first use, (2) public bodies or private entities providing public services are deploying AI systems, (3) credit scoring or insurance risk assessment AI systems are being deployed (Annex III 5b, 5c), (4) evaluating impact on natural persons' fundamental rights (dignity, liberty, privacy, data protection, non-discrimination, children's rights, etc.), or (5) creating EU AI Act Article 27 compliance documentation with market surveillance notification.

日本語の概要は準備中です。原文の説明を表示しています。

Select, install, and name the authoritative compiler, simulator, solver, or other external verifier for an Anabasis harness. Use when deciding which practitioner tool to trust, writing the truth check that runs it, or diagnosing verifierUnavailable, timeout, crash or sandbox results. Also owns the install probe, the executable board for what the Builder can install and run behind the real cells and wall. Use harness-contract (discrimination proof) for semantic accept/reject coverage.

日本語の概要は準備中です。原文の説明を表示しています。

Design, change or audit one Anabasis contract: adoption gates, verifier discrimination, artifact representation and the tools over it (including whether a tool earns its place from recorded use), model-visible text, or coding discipline including a small rule-changing fix. Load only the relevant area; source and AGENTS.md own current mechanisms and authority.

日本語の概要は準備中です。原文の説明を表示しています。

Redact rendered visual artifacts — Mermaid diagrams, SVGs, and HTML dashboards — before public disclosure, using an ordered longest-first mapping table (specific label, then namespace label, then catch-all placeholder) that swaps sensitive identifiers for descriptive stand-ins while preserving structure, node ids, and teaching value. Covers whole-word identifier replacement, node-label-vs-node-id discrimination, re-rendering the derived image from the redacted source, and verifying the result through the redaction gate. Use when a diagram or dashboard built from internal findings must ship to a public mirror without leaking the names behind it.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts a court-ready ADA failure-to-accommodate complaint under Title I (employment, 42 U.S.C. § 12112) or Title III (public accommodations, 42 U.S.C. § 12182). Structures jurisdiction, EEOC exhaustion, factual allegations, causes of action, and relief. Use when drafting ADA disability discrimination complaints, reasonable accommodation pleadings, or civil rights complaints for plaintiffs with disabilities.

日本語の概要は準備中です。原文の説明を表示しています。

Drafts an ADA failure-to-accommodate complaint for federal or state court filing. Covers Title I employment (42 U.S.C. § 12112) and Title III public accommodations (42 U.S.C. § 12182), including EEOC exhaustion, interactive process failures, and prayer for relief. Use when drafting an ADA complaint, disability discrimination pleading, failure-to-accommodate lawsuit, or right-to-sue complaint.

日本語の概要は準備中です。原文の説明を表示しています。

Professional network graph analyst identifying Gladwellian superconnectors, mavens, and influence brokers using betweenness centrality, structural holes theory, and multi-source network reconstruction. Activate on 'superconnectors', 'network analysis', 'who knows who', 'professional network', 'influence mapping', 'betweenness centrality'. NOT for surveillance, discrimination, stalking, privacy violation, or speculation without data.

日本語の概要は準備中です。原文の説明を表示しています。

Validates predictive models on omics and biomedical data with nested cross-validation, group/batch/temporal-aware splits, the full data-leakage taxonomy, probability calibration, decision-curve net benefit, optimism correction, sample-size planning, and TRIPOD+AI reporting. Use when estimating model performance honestly, choosing a CV scheme, detecting leakage, or judging whether reported discrimination means the model is actually useful. For feature selection itself see machine-learning/biomarker-discovery; for confirmatory-trial inference see clinical-biostatistics/trial-reporting.

日本語の概要は準備中です。原文の説明を表示しています。